Real-World Evidence Studies can Enhance Diversity and Equity in Clinical Research
Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.
How to Transition RWE Studies from Non-Clinical to Regulatory-Grade
The FDA has been working to enable greater adoption of RWE in clinical and regulatory decisions, as mandated by the 21st Century Cures Act.